Panagora Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-37,795
| Closed | -$3.51M | – | 1643 |
|
|
2021
Q4 | $3.51M | Sell |
37,795
-39,473
| -51% | -$2.6M | 0.02% | 485 |
|
|
2021
Q3 | $4.6M | Sell |
77,268
-685
| -0.9% | -$40.5K | 0.02% | 447 |
|
|
2021
Q2 | $5.32M | Sell |
77,953
-2,595
| -3% | -$169K | 0.03% | 433 |
|
|
2021
Q1 | $5.59M | Sell |
80,548
-4,768
| -6% | -$367K | 0.03% | 439 |
|
|
2020
Q4 | $6.55M | Sell |
85,316
-80,335
| -48% | -$6.02M | 0.04% | 373 |
|
|
2020
Q3 | $12.4M | Sell |
165,651
-35,429
| -18% | -$2.36M | 0.08% | 222 |
|
|
2020
Q2 | $12.7M | Buy |
201,080
+9,263
| +5% | +$510K | 0.08% | 227 |
|
|
2020
Q1 | $8.06M | Sell |
191,817
-103,425
| -35% | -$4.74M | 0.06% | 262 |
|
|
2019
Q4 | $13.4M | Buy |
295,242
+222,566
| +306% | +$10.5M | 0.06% | 285 |
|
|
2019
Q3 | $3.33M | Buy |
72,676
+69,102
| +1,933% | +$3.88M | 0.02% | 575 |
|
|
2019
Q2 | $210K | Sell |
3,574
-445
| -11% | -$23K | ﹤0.01% | 1779 |
|
|
2019
Q1 | $180K | Sell |
4,019
-4,166
| -51% | -$191K | ﹤0.01% | 1743 |
|
|
2018
Q4 | $319K | Sell |
8,185
-37,547
| -82% | -$1.47M | ﹤0.01% | 1476 |
|
|
2018
Q3 | $2.1M | Sell |
45,732
-72,772
| -61% | -$2.95M | 0.01% | 820 |
|
|
2018
Q2 | $5.17M | Sell |
118,504
-7,657
| -6% | -$329K | 0.02% | 515 |
|
|
2018
Q1 | $4.98M | Sell |
126,161
-226
| -0.2% | -$8.79K | 0.02% | 536 |
|
|
2017
Q4 | $4.29M | Buy |
126,387
+4,010
| +3% | +$114K | 0.02% | 597 |
|
|
2017
Q3 | $3.12M | Sell |
122,377
-7
| -0% | -$161 | 0.01% | 700 |
|
|
2017
Q2 | $2.06M | Buy |
122,384
+702
| +0.6% | +$9.63K | 0.01% | 844 |
|
|
2017
Q1 | $1.78M | Buy |
121,682
+43,462
| +56% | +$644K | 0.01% | 924 |
|
|
2016
Q4 | $1.11M | Buy |
+78,220
| New | +$1.21M | 0.01% | 1168 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 2403 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 2468 |
|
Panagora Asset Management's ARNA Position: Q1 2022 in Review
Panagora Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 37,795 shares — an estimated $3.51M sold.
Panagora Asset Management first reported a position in ARNA in Q4 2016 and held it in 21 quarters. The position peaked at $13.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Panagora Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Panagora Asset Management sold 37,795 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.51M.
- Panagora Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2016 and held it in 21 quarters.
- Panagora Asset Management's Arena Pharmaceuticals Inc position peaked at $13.4M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Panagora Asset Management's 13F filing for Q1 2022, filed 12 May 2022.